FR2614025B1 - PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS - Google Patents

PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS

Info

Publication number
FR2614025B1
FR2614025B1 FR8705398A FR8705398A FR2614025B1 FR 2614025 B1 FR2614025 B1 FR 2614025B1 FR 8705398 A FR8705398 A FR 8705398A FR 8705398 A FR8705398 A FR 8705398A FR 2614025 B1 FR2614025 B1 FR 2614025B1
Authority
FR
France
Prior art keywords
viruses
peptides
diagnosis
recognized
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8705398A
Other languages
French (fr)
Other versions
FR2614025A1 (en
Inventor
Pierre Sonigo
Pierre Tiollais
Mireille Guyader
Marc Alizon
Lisa Chakrabarti
Ronald Desrosiers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8705398A priority Critical patent/FR2614025B1/en
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Priority to DE3856595T priority patent/DE3856595D1/en
Priority to JP63501472A priority patent/JP2948823B2/en
Priority to EP96108720A priority patent/EP0750041B1/en
Priority to AT96108720T priority patent/ATE417108T1/en
Priority to EP88400084A priority patent/EP0283327B1/en
Priority to AT88400084T priority patent/ATE154808T1/en
Priority to ES88400084T priority patent/ES2104556T3/en
Priority to AU12250/88A priority patent/AU608294B2/en
Priority to DE3855947T priority patent/DE3855947T2/en
Priority to PCT/FR1988/000025 priority patent/WO1988005440A1/en
Priority to CA000557174A priority patent/CA1341520C/en
Priority to CA617168A priority patent/CA1341634C/en
Priority to KR1019880701183A priority patent/KR0135885B1/en
Priority to OA59284A priority patent/OA08716A/en
Priority to MX010385A priority patent/MX169441B/en
Priority to NZ223494A priority patent/NZ223494A/en
Priority to PT8675288A priority patent/PT86752B/en
Priority to IE19990955A priority patent/IE990955A1/en
Priority to DK198805133A priority patent/DK174705B1/en
Publication of FR2614025A1 publication Critical patent/FR2614025A1/en
Application granted granted Critical
Publication of FR2614025B1 publication Critical patent/FR2614025B1/en
Priority to JP7117839A priority patent/JP2862810B2/en
Priority to GR970402458T priority patent/GR3024823T3/en
Priority to JP11099449A priority patent/JPH11322792A/en
Priority to JP2001133477A priority patent/JP2002030099A/en
Priority to DK200201277A priority patent/DK175879B1/en
Priority to JP2003140638A priority patent/JP2004002421A/en
Priority to DK200301628A priority patent/DK176372B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FR8705398A 1987-01-16 1987-04-15 PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS Expired - Lifetime FR2614025B1 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
FR8705398A FR2614025B1 (en) 1987-04-15 1987-04-15 PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
JP63501472A JP2948823B2 (en) 1987-01-16 1988-01-15 Human immunodeficiency retrovirus (HIV) -related antigenic peptide, detection of viral infection and use in vaccine
EP96108720A EP0750041B1 (en) 1987-01-16 1988-01-15 HIV-2 and SIV-1 nucleotide sequences
AT96108720T ATE417108T1 (en) 1987-01-16 1988-01-15 HIV-2 AND SIV-1 NUCLEOTIDE SEQUENCES
DE3856595T DE3856595D1 (en) 1987-01-16 1988-01-15 HIV-2 and SIV-1 nucleotide sequences
EP88400084A EP0283327B1 (en) 1987-01-16 1988-01-15 Peptides with the immunological properties of HIV-2
AT88400084T ATE154808T1 (en) 1987-01-16 1988-01-15 PEPTIDES WITH THE IMMUNOLOGICAL PROPERTIES OF HIV-2
ES88400084T ES2104556T3 (en) 1987-01-16 1988-01-15 PEPTIDES THAT HAVE IMMUNOLOGICAL PROPERTIES OF HIV-2.
AU12250/88A AU608294B2 (en) 1987-01-16 1988-01-15 Peptides having immunological properties 2-hiv-2
DE3855947T DE3855947T2 (en) 1987-01-16 1988-01-15 Peptides with the immunological properties of HIV-2
PCT/FR1988/000025 WO1988005440A1 (en) 1987-01-16 1988-01-15 Peptides having immunological properties 2-hiv-2
CA000557174A CA1341520C (en) 1987-02-11 1988-01-22 Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination
CA617168A CA1341634C (en) 1987-02-11 1988-01-22 Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humanin (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
KR1019880701183A KR0135885B1 (en) 1987-01-16 1988-01-25 Peptides recognized by antibodies against hiv
OA59284A OA08716A (en) 1987-02-11 1988-02-10 Peptides capable of being recognized by antibodies induced against human immunodeficiency retroviruses (HIV viruses), their applications in the diagnosis of infections due to certain of these viruses and, where appropriate, in vaccination against AIDS.
MX010385A MX169441B (en) 1987-02-11 1988-02-11 PEPTIDES ABLE TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST RETRO-VIRUSES OF HUMAN IMMUNODEFICIENCY (HIV-VIRUSES) AND THEIR APPLICATIONS FOR DIAGNOSIS OF INFECTIONS CAUSED BY SOME OF THESE VIRUSES AND, IF ANY, WITH VACCINES
NZ223494A NZ223494A (en) 1987-02-11 1988-02-11 Peptides, nucleic acids and oligonucleotides related to sequences of hiv-2 and siv-1
PT8675288A PT86752B (en) 1987-02-11 1988-02-11 A PROCESS FOR THE PREPARATION OF SUSCEPTIVE PEPTIDES TO BE RECOGNIZED BY HUMAN IMMUNODEFICIENCY INDUCED RETROVIRUS (HIV VIRUS) ITS APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS CAUSED BY SOME OF THESE VIRUSES AND IN SUCH CIRCUMSTANCES THE VACCINATION AGAINST AIDS
IE19990955A IE990955A1 (en) 1987-02-11 1988-02-11 Peptides capable of being recognized by antibodies induced against retro-viruses of human immunodeficiency (HIV viruses), their uses for the diagnosis of infections due to some of these viruses and, where appropriate, for vaccination against AIDS
DK198805133A DK174705B1 (en) 1987-01-16 1988-09-15 Peptides having immunological properties corresponding to HIV-2 viruses, antigens and immunogenic agents containing such peptides, and methods and kits for an in vitro diagnosis of HIV-2
JP7117839A JP2862810B2 (en) 1987-01-16 1995-04-19 Immunodeficiency retrovirus (HIV) -related antigenic peptide and nucleic acid sequence encoding the same
GR970402458T GR3024823T3 (en) 1987-01-16 1997-09-24 Peptides with the immunological properties of HIV-2
JP11099449A JPH11322792A (en) 1987-01-16 1999-04-06 Peptide detectable by antibody derived against human immunodeficient retrovirus (virus hiv), and use of said peptide in diagnosis of infection caused by a certain kind of said virus, and optional use of said peptide in innoculation of vaccine against aids
JP2001133477A JP2002030099A (en) 1987-01-16 2001-04-27 Peptide recognizable by antibody induced against human immunodeficiency virus (virus hiv), diagnosis of infection caused by species of the same virus and use of species of the same peptide in inoculation of vaccine against aids in some case
DK200201277A DK175879B1 (en) 1987-01-16 2002-08-30 NEw peptide(s) with immunological properties of HIV-2 envelope protein - have the structure of simian immune deficiency virus proteins, useful in diagnosis and of vaccine components
JP2003140638A JP2004002421A (en) 1987-01-16 2003-05-19 Peptide recognized by antibody induced against human immunodeficiency retrovirus (virus hiv), diagnosis for infection caused by a species of the same virus, and in some cases, use of the same peptide in inoculation of vaccine for aids
DK200301628A DK176372B1 (en) 1987-01-16 2003-11-03 NEw peptide(s) with immunological properties of HIV-2 envelope protein - have the structure of simian immune deficiency virus proteins, useful in diagnosis and of vaccine components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705398A FR2614025B1 (en) 1987-04-15 1987-04-15 PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS

Publications (2)

Publication Number Publication Date
FR2614025A1 FR2614025A1 (en) 1988-10-21
FR2614025B1 true FR2614025B1 (en) 1990-05-18

Family

ID=9350180

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8705398A Expired - Lifetime FR2614025B1 (en) 1987-01-16 1987-04-15 PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS

Country Status (1)

Country Link
FR (1) FR2614025B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (en) * 1987-04-16 1987-04-16 Erling Norrby MEANS OF ANALYSIS MM
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583293D1 (en) * 1984-10-18 1991-07-25 Pasteur Institut LYMPHADENOPATHY-ASSOCIATED SHELL ANTIGENS AND THEIR USE.
FR2593189B1 (en) * 1986-01-22 1989-10-20 Pasteur Institut NEW RETROVIRUS THAT MAY CAUSE AIDS, ANTIGENS OBTAINED FROM THIS RETROVIRUS AND CORRESPONDING ANTIBODIES AND THEIR APPLICATIONS TO AIDS DIAGNOSIS

Also Published As

Publication number Publication date
FR2614025A1 (en) 1988-10-21

Similar Documents

Publication Publication Date Title
DE69632256D1 (en) ANTIVIRAL PROTEINS, CODING DNA, AND THEIR USE
EA200200724A1 (en) VACCINE FOR PREVENTION OR THERAPEUTIC IMMUNIZATION AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY (HIV)
BR9712289A (en) Compositions and methods for the treatment of viral infections
DE59003895D1 (en) Working pliers.
WO1989006276A3 (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
ATE78696T1 (en) MEDICINAL PREPARATION FOR THE TREATMENT OF IMMUNE DEFICIENCY.
FR2647810B1 (en) OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-2 AND SIV RETROVIRUSES, AND THEIR APPLICATIONS TO THE IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
FR2614025B1 (en) PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
EP0311107A3 (en) Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
FR2610632B1 (en) CHARACTERISTIC PEPTIDES OF HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN OF THESE VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
KR890009415A (en) Antiviral compound and preparation method thereof
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
FR2647809B1 (en) OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
RU93058325A (en) APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS
FI881123A0 (en) INACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) MEDICINES IN PHENOL AND PROTEIN INHALATION.
ATE284709T1 (en) VIRAL CHIMERAS FROM CAEV AND HIV-1 GENETIC ELEMENTS
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids
EP0250128A3 (en) Novel virus isolated from patients with aids
RU96116005A (en) STRAIN HOMINIS IMMUNODEFICITI VIRUS (HIV-I) HIV-I / RUSSIA / GM-12-95 (RU1295) SUBTYPE B FOR DIAGNOSTIC AND VACCINE DRUGS
OA08716A (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retroviruses (HIV viruses), their applications in the diagnosis of infections due to certain of these viruses and, where appropriate, in vaccination against AIDS.
FR2382237A1 (en) NEW MERCAPTAN-BASED BLOOD SERUM PREPARATIONS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
ZA899533B (en) Medication for the treatment or prevention of hiv-virus infection through passive immunization and processes for its preparation
FR2652091B1 (en) NUCLEOTIDE SEQUENCES ARISING FROM THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES, AND THEIR APPLICATIONS IN PARTICULAR FOR THE AMPLIFICATION OF THE GENOMES OF THESE RETROVIRUSES AND FOR THE IN-VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES.
Barnett et al. Human immunodeficiency viruses.

Legal Events

Date Code Title Description
CD Change of name or company name
CL Concession to grant licences
AU Other action affecting the ownership or exploitation of an industrial property right
CL Concession to grant licences